Control de azúcar en sangre
The global continuous glucose monitoring (CGM) market is undergoing a transformative shift, driven by technological innovation and increased demand for affordable diabetes management solutions. Among the key players reshaping this landscape are Chinese manufacturers like SIBIONICS, whose strategic entry into...
sigue leyendo
The global continuous glucose monitoring (CGM) market has witnessed exponential growth over the past decade, driven by technological advancements, rising diabetes prevalence, and increased awareness of metabolic health. However, questions about the economic sustainability of CGM adoption and its long...
sigue leyendo
Metabolic Health Optimization: Preventing Insulin Resistance Nearly 34% of adults globally have prediabetes, yet many remain undiagnosed12. CGM devices like GS1 offer proactive solutions: Dietary Insights: Identify glucose spikes from specific foods (e.g., refined carbs), enabling personalized nutrition plans79. Early...
sigue leyendo
CGM Industry Trends: From Diabetes Care to Holistic Health Management The global Continuous Glucose Monitoring (CGM) market is undergoing a paradigm shift. While early adoption focused on Type 1 diabetes, advancements in non-invasive technology and cost reduction are driving demand...
sigue leyendo
Introduction For individuals using continuous glucose monitoring (CGM) systems like the Sibionics GS1, the Ambulatory Glucose Profile (AGP) report is a crucial tool for understanding and managing glucose levels. This report provides a comprehensive overview of glucose patterns over a...
sigue leyendo